Skip to main content

Table 3 Laboratory evaluation of immune status of SARS survivors

From: Investigation of the impact of SARS-CoV infection on the immunologic status and lung function after 15 years

 

The severe group (N = 23)

The non-severe group (N = 35)

The control group (N = 57)

F/T value

P-value

IgA (G/L)

2.20 ± 0.97

2.41 ± 0.97

2.21 ± 0.73

0.555

0.576

IgG (G/L)

11.84 ± 1.97

12.80 ± 2.32

12.94 ± 2.18

2.985

0.055

IgM (G/L)

0.98 ± 0.40

1.03 ± 0.38

1.09 ± 0.45

0.742

0.478

C3 (G/L)

0.88 ± 0.13

0.98 ± 0.18

0.94 ± 0.18

2.928

0.058

C4 (G/L)

0.22 ± 0.06

0.27 ± 0.18

0.22 ± 0.06

3.547

0.032

CD4 + (%)

50.69 ± 13.21

51.82 ± 10.25

51.20 ± 10.10

0.071

0.931

CD8 + (%)

40.82 ± 10.97

39.71 ± 10.61

38.48 ± 9.75

0.569

0.568

CD4 + CD25 + Foxp3 + (%)

3.84 ± 1.43

3.89 ± 1.12

3.34 ± 0.97

2.862

0.061

  1. IgA immunoglobulin A, normal value 0.82–4.53 g/L, IgG immunoglobulin G, normal value 7.2–16.8 g/L, IgM immunoglobulin M, normal value 0.46–3.04 g/L, C3 complement3, normal value 0.79–1.52 d/L, C4 complement4, normal value 0.16–0.38
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us